Combined blood and pleural levels of mesothelin and osteopontin for the diagnosis of malignant pleural mesothelioma
Background: Malignant pleural mesothelioma (MPM) is a highly aggressive tumor with poor survival rate. It is difficult to diagnose MPM at an early stage. Soluble mesothelin remains the best available biomarker for MPM, however the lack of sensitivity for early stage disease provides a motivation for...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2012-07-01
|
Series: | Egyptian Journal of Chest Disease and Tuberculosis |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0422763812000179 |